STRAIGHT FROM
LIVE

Serial Number

79218573

Owner

MILTENYI BIOTEC B.V. & CO. KG

Attorney

Peter S. Sloane

Filing Date

Jun 1, 2017

Add to watchlist:

No watchlists yet
View on USPTO

STRAIGHT FROM Trademark

Serial Number: 79218573 • Registration: 5614037

STRAIGHT FROM is a trademark filed by MILTENYI BIOTEC B.V. & CO. KG on June 1, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

MILTENYI BIOTEC B.V. & CO. KG (38 trademarks)

BERGISCH GLADBACH 51429 , DE

Entity Type: 30

Miltenyi Biotec GmbH (30 trademarks)

Friedrich-Ebert-Strabe 68
51429 Bergisch Gladbach , DE

Entity Type: 03

Trademark Details

Filing Date

June 1, 2017

Registration Date

November 27, 2018

Published for Opposition

September 11, 2018

Goods & Services

[ Chemical, ] biological and biochemical products for industrial, scientific and non-medical diagnostic purposes, namely, [ chemicals, ] biological preparations and biochemicals for use in separation processes for biological materials; reagents for scientific and research use, namely, for use in separation processes for biological materials; reagents for cell separation for scientific and research use; cell labeling reagents for scientific and research use; [ substances and ingredients, namely, biological and chemical substances all for the preparation of cell culturing media, and all for scientific purposes and for the use in medical laboratories; ] reagents for scientific and research use, namely, for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of chemical and biological materials; reagents with magnetic beads for scientific and research use; antibody reagents, other than for medical or veterinary purposes; [ buffer solutions and reagents for use with laboratory instruments, especially separation instruments, analysis instruments, reactors and imaging instruments, and other than for medical or veterinary purposes; ] reagents for processing of biological materials, especially tissue, bone marrow, cells, blood and its components, and other than for medical or veterinary purposes; diagnostic reagents and preparations for scientific purposes and for use in medical laboratories; [ microorganism culture media, cell culture media, contrast agents, and contrast agents for in-vivo imaging, all for scientific purposes; chemical and ] biological reagents, other than for medical or veterinary purposes, namely, for use in biotechnology, in biological treatment processes and in the biotechnology industry

[ Scientific, optical and measuring apparatus and instruments, namely, instruments for the separation, analysis, processing and cultivation of biological material all for scientific or laboratory use; apparatus for recording, transmission or reproduction of images; data processing equipment; computer software for recording data related to the separation, analysis processing, and cultivation of biological material; scientific, electrical and electronic apparatus and instruments for conducting enzymatic reactions, namely, laboratory chemical reactors for use in separation processes for biological materials; laboratory equipment, namely, cytometer for measuring physical and chemical properties of cells and other particles in suspensions ]

[ Pharmaceutical, medical and veterinary products as well as ] products for the pharmaceutical, medical and veterinary science, namely, cell culture media and reagents for use in separation processes for biological materials for medical or veterinary purposes; [ pharmaceutical and other preparations for medical or veterinary purposes, namely, cell culture media and ] reagents for use in separation processes for biological materials; [ chemical and biological reagents for medical or veterinary purposes; cell culturing media for cultivating stem cells, tissue cells, immune cells and microorganism cells all for medical or veterinary purposes; ] reagents for medical use, namely, for the processing, separation, isolation, enrichment, depletion, detection, screening, analysis and counting of biological materials; reagents with magnetic beads and antibody reagents, all for medical or veterinary purposes; [ buffer solutions and ] reagents for use with medical instruments, especially separation instruments, analysis instruments, reactor and imaging instruments and all for medical purposes; reagents for the processing of biological materials, especially tissue, bone marrow, cells, blood and its components, and all for medical or veterinary purposes; [ cell culture media for cultivating stem cells, tissue cells, immune cells and microorganisms, and diagnostic reagents and preparations all for medical and veterinary purposes; contrast agents, and contrast agents for in-vivo imaging, all for medical and veterinary purposes; ] pharmaceutical products, namely, pharmaceutical preparations for cellular therapy

[Scientific and technological services, namely, scientific research, analysis and testing in the fields of cell separation and isolation and new product research and design services relating hereto; industrial analysis and research services in the field of cell separation and isolation; design and development of computer hardware and software for use in the analysis of biological and biochemical material, especially of cellular material for biological and medical research and therapy]

[Surgical apparatus and instruments; medical, dental and veterinary apparatus and instruments, namely, apparatus for magnetic cell separation for use in separation processes for biological materials; tubing sets for medical purposes, namely, drainage and transfusion tubing sets for medical purposes; sacks, bags, sheets, tubes and connectors for medical and medical biotechnological purposes, in particular for the collection of biological material for cryopreservation; apparatus and instruments for medical and biotechnological purposes, namely, apparatus for magnetic cell separation for use in separation processes for biological materials all for medical purposes; accessories for the aforesaid goods, namely, medical bags, sack tubes, and connectors for use in separation processes for biological materials for medical purposes and structural replacement parts for the aforesaid goods]

Filing History

PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Dec 15, 2025 INPR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 15, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 15, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 15, 2025 REAP
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
Apr 15, 2025 NA71
REGISTERED - PARTIAL SEC 71 ACCEPTED
Apr 15, 2025 71.P
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Apr 7, 2025 APRE
TEAS SECTION 71 RECEIVED
Nov 12, 2024 ES71
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Nov 27, 2023 REM3
CHANGE OF OWNER RECEIVED FROM IB
Dec 5, 2019 CHLD
FINAL DECISION TRANSACTION PROCESSED BY IB
Mar 22, 2019 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Mar 6, 2019 FICS
FINAL DISPOSITION PROCESSED
Mar 6, 2019 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Feb 28, 2019 FICR
REGISTERED-PRINCIPAL REGISTER
Nov 27, 2018 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 11, 2018 NPUB
PUBLISHED FOR OPPOSITION
Sep 11, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Sep 7, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Aug 22, 2018 OPNS
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 22, 2018 NONP
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Aug 22, 2018 OP2R
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 2, 2018 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 2, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 2, 2018 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Aug 2, 2018 ERFR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jul 31, 2018 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jul 31, 2018 REAP
FINAL REFUSAL MAILED
Jun 8, 2018 CNFR
FINAL REFUSAL WRITTEN
Jun 7, 2018 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
May 14, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
May 14, 2018 CRFA
ASSIGNED TO LIE
May 9, 2018 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
May 3, 2018 TROA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Dec 20, 2017 ECDR
REFUSAL PROCESSED BY IB
Nov 24, 2017 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Nov 3, 2017 RFCS
REFUSAL PROCESSED BY MPU
Nov 3, 2017 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Oct 27, 2017 RFCR
NON-FINAL ACTION WRITTEN
Oct 26, 2017 CNRT
APPLICATION FILING RECEIPT MAILED
Oct 24, 2017 MAFR
ASSIGNED TO EXAMINER
Oct 20, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 20, 2017 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Oct 19, 2017 REPR